Progesterone is a steroid hormone produced primarily by the corpus luteum after ovulation and by the placenta during pregnancy. It regulates the secretory transformation of the endometrium, supports pregnancy, reduces uterine contractility, influences the hypothalamic-pituitary-gonadal axis, and contributes to mammary gland development.
Progesterone is a steroid hormone with central roles in the ovarian cycle, menstrual cycle, implantation, pregnancy, and mammary gland development. In the nonpregnant reproductive cycle, its major source is the corpus luteum, a temporary endocrine structure formed from the ovarian follicle after ovulation. During pregnancy, the placenta becomes a major source of progesterone.
Progesterone acts primarily on tissues that have been prepared by estrogen, particularly the endometrium. After ovulation, rising progesterone transforms the estrogen-stimulated proliferative endometrium into a secretory endometrium capable of supporting implantation and early embryonic development. Progesterone also modifies cervical mucus, influences the uterine tubes, decreases myometrial excitability, contributes to breast development, and provides negative feedback within the hypothalamic-pituitary-gonadal axis.
Because progesterone concentrations change dramatically across the ovarian cycle, the hormone serves as one of the major endocrine signals distinguishing the follicular and luteal phases.
Progesterone is a steroid hormone derived from cholesterol. It belongs to the class of steroid hormones known as progestogens.
Like other steroid hormones, progesterone is lipid soluble and can cross cell membranes to interact primarily with intracellular receptors.
| Source | Physiological Context |
|---|---|
| Corpus luteum | Major source during the luteal phase of the ovarian cycle |
| Placenta | Major source during much of pregnancy |
| Ovarian follicles | Small amounts produced during follicular steroidogenesis |
| Adrenal glands | Small quantities and steroidogenic intermediate |
The ovary becomes a major source of progesterone after ovulation. Before ovulation, progesterone concentrations are relatively low compared with those of the luteal phase.
The dramatic postovulatory rise occurs when cells of the ruptured follicle undergo luteinization and form the corpus luteum.
Ovulation is triggered by the midcycle LH surge. Following rupture of the mature follicle and release of the secondary oocyte, the remaining granulosa and theca cells undergo structural and functional transformation.
This process, called luteinization, converts the postovulatory follicle into a highly vascular endocrine structure specialized for steroid hormone secretion.
The corpus luteum is a temporary ovarian endocrine gland formed after ovulation. It occupies the site of the ruptured follicle and becomes the dominant source of ovarian progesterone during the luteal phase.
It also produces estradiol, inhibin A, and other regulatory factors.
After ovulation, granulosa cells enlarge and differentiate into granulosa lutein cells. These cells are major contributors to progesterone production within the corpus luteum.
Luteinization changes their steroidogenic enzyme expression and allows substantial progesterone secretion.
Cells derived from the theca interna differentiate into theca lutein cells. They occupy a more peripheral position within the corpus luteum and contribute to luteal steroidogenesis.
Interactions between granulosa lutein and theca lutein cells support the endocrine function of the corpus luteum.
Luteinizing hormone (LH) is essential for normal corpus luteum formation and function during the nonpregnant ovarian cycle.
LH receptor signaling promotes steroidogenesis and supports progesterone secretion by luteal cells.
Progesterone is synthesized from cholesterol. Cholesterol is transported into mitochondria, where the steroidogenic pathway begins.
The first major steroid product is pregnenolone, which is subsequently converted to progesterone.
| Step | Process |
|---|---|
| 1 | Cholesterol is made available to steroidogenic cells |
| 2 | Cholesterol is transported into mitochondria |
| 3 | Cholesterol is converted to pregnenolone |
| 4 | Pregnenolone is converted to progesterone |
| 5 | Progesterone diffuses from the steroidogenic cell into the circulation |
Pregnenolone is produced from cholesterol and serves as an important precursor for steroid hormone synthesis.
It can be converted into progesterone by the action of 3β-hydroxysteroid dehydrogenase and associated steroidogenic machinery.
Progesterone is not only a biologically active hormone. It also occupies an important position within steroidogenic pathways leading to glucocorticoids, mineralocorticoids, and androgens in appropriate endocrine tissues.
The final products generated from steroid precursors depend on the enzymes expressed by each steroidogenic tissue.
Circulating progesterone concentrations are relatively low during most of the follicular phase. Developing follicles are primarily characterized by increasing estrogen production.
A modest increase in progesterone production occurs around the periovulatory period as the mature follicle begins luteinization-related changes.
After ovulation, progesterone concentrations rise substantially as the corpus luteum develops.
The luteal phase is therefore the progesterone-dominant portion of the ovarian cycle.
Progesterone generally reaches high concentrations during the midluteal phase when the corpus luteum is maximally functional.
This hormonal environment corresponds with maximal secretory transformation of the endometrium.
| Cycle Stage | Progesterone Pattern | Major Source |
|---|---|---|
| Early follicular phase | Low | Minimal ovarian secretion |
| Late follicular phase | Generally low with periovulatory increase | Mature follicle |
| Early luteal phase | Rapidly rising | Developing corpus luteum |
| Midluteal phase | High | Functional corpus luteum |
| Late luteal phase without pregnancy | Falls | Regressing corpus luteum |
| Pregnancy | Maintained and progressively supported by placental production | Corpus luteum initially, then placenta becomes the major source |
The endometrium is one of the most important progesterone target tissues. During the follicular phase, estrogen stimulates proliferation of the functional endometrial layer.
After ovulation, progesterone acts on this estrogen-primed tissue and converts it from a proliferative state into a secretory state.
Progesterone promotes the secretory transformation of endometrial glands. The glands become increasingly tortuous and develop secretory activity.
The endometrial stroma and vascular environment also undergo changes that prepare the uterus for possible implantation.
The uterine secretory phase corresponds approximately to the ovarian luteal phase. It begins after ovulation under the influence of progesterone from the corpus luteum.
The functional endometrium becomes structurally and biochemically prepared for interaction with an implanting blastocyst.
Progesterone stimulates secretory changes within endometrial glands that had proliferated under estrogenic influence.
These glands provide a nutrient-rich environment during the period when an early conceptus may enter the uterine cavity and begin implantation.
Progesterone also affects stromal cells of the endometrium. During the late luteal phase and particularly during pregnancy, stromal cells can undergo decidualization.
Decidualized cells form an important component of the maternal tissue surrounding an implanted embryo.
Decidualization is the transformation of endometrial stromal cells into specialized decidual cells under hormonal influence, particularly progesterone.
This process is essential for normal implantation, placental development, and regulation of the maternal-fetal interface.
Successful implantation requires an appropriately prepared endometrium. Progesterone creates the postovulatory endometrial environment necessary for uterine receptivity.
Its actions occur in coordination with preceding estrogen exposure and numerous local signaling molecules.
The endometrium becomes optimally receptive to implantation during a limited period of the secretory phase. This period is commonly referred to as the window of implantation.
Progesterone-dependent changes in epithelial, glandular, stromal, vascular, and molecular characteristics contribute to this receptive state.
If pregnancy does not occur, the corpus luteum undergoes luteolysis and progesterone concentrations fall.
Progesterone withdrawal is a major endocrine event leading to breakdown and shedding of the functional endometrial layer during menstruation.
The decline in progesterone and estrogen after corpus luteum regression triggers molecular and vascular changes within the endometrium.
These changes ultimately result in shedding of the functional layer and menstrual bleeding.
The functional endometrium is supplied by spiral arteries. During the luteal phase, the endometrial vascular system undergoes progesterone-dependent changes as the tissue prepares for implantation.
When ovarian steroid support is withdrawn, vascular and inflammatory processes contribute to menstrual breakdown.
Progesterone contributes to maintenance of a relatively quiescent uterine environment. It reduces myometrial excitability and modifies signaling pathways involved in uterine contractility.
This function becomes especially important during pregnancy.
The myometrium is the smooth muscle layer of the uterus. Its contractile state is influenced by multiple hormones, receptors, ion channels, and local signaling molecules.
Progesterone favors mechanisms that limit excessive uterine contractions during pregnancy.
Progesterone influences the uterine signaling environment associated with contractility, including pathways related to oxytocin responsiveness.
Near parturition, changes in the balance of progesterone-dependent and estrogen-dependent signaling contribute to increased uterine responsiveness.
Progesterone influences the properties of cervical mucus. After ovulation, cervical mucus generally becomes thicker and less favorable to sperm penetration than the thin, more permeable mucus associated with high preovulatory estrogen.
This cyclic change reflects the transition from estrogen dominance to progesterone dominance.
Progesterone influences secretory and muscular activity within the uterine tubes. Together with estrogen, it helps regulate the tubal environment encountered by gametes and the early embryo.
Progesterone contributes to cyclic changes in the reproductive tract, including changes in vaginal epithelial characteristics.
Its effects occur within the broader hormonal environment created by estrogen and other reproductive signals.
Progesterone contributes to development and differentiation of the mammary glands. It acts particularly on the lobuloalveolar structures of the breast.
Its effects occur together with estrogen, prolactin, growth hormone, and other hormonal signals.
Estrogen is particularly important for ductal development, while progesterone contributes substantially to development of the lobules and alveolar structures associated with secretory function.
During pregnancy, extensive mammary differentiation occurs under the combined influence of multiple hormones.
Progesterone participates in feedback regulation of the hypothalamic-pituitary-gonadal axis.
During the luteal phase, progesterone acts together with estrogen and inhibin to suppress gonadotropin secretion and prevent inappropriate initiation of another follicular cycle.
Progesterone influences hypothalamic regulation of gonadotropin-releasing hormone (GnRH). One important effect is modification of the frequency and pattern of GnRH pulsatility.
These changes contribute to the characteristic gonadotropin environment of the luteal phase.
Progesterone contributes to negative feedback at the pituitary as part of the luteal endocrine environment.
The combined effects of progesterone, estradiol, and inhibin maintain relatively suppressed gonadotropin secretion while the corpus luteum remains active.
LH is required for normal luteal function, while progesterone produced by the corpus luteum contributes to feedback that modifies subsequent LH secretion.
This creates a regulatory relationship between pituitary gonadotropin output and ovarian luteal activity.
Progesterone contributes to the hormonal environment suppressing FSH during the luteal phase. Estradiol and inhibin A also participate importantly in this suppression.
When the corpus luteum regresses, falling progesterone, estrogen, and inhibin permit FSH to begin rising again.
Luteolysis is the structural and functional regression of the corpus luteum when pregnancy does not occur.
As luteal cells lose steroidogenic function, circulating progesterone concentrations decline sharply.
Following luteolysis, the corpus luteum is progressively replaced by fibrous scar tissue known as the corpus albicans.
This marks the end of the endocrine function of that particular postovulatory follicle.
If fertilization and implantation occur, progesterone production must be maintained because premature loss of luteal progesterone would compromise the early pregnancy-supporting endometrium.
The developing conceptus provides an endocrine signal that rescues the corpus luteum from its normal cyclic regression.
Human chorionic gonadotropin (hCG) is produced initially by trophoblastic tissue associated with the developing conceptus. Its structure and receptor activity allow it to stimulate the LH receptor.
hCG therefore maintains corpus luteum steroidogenesis during early pregnancy.
The rescued corpus luteum, often called the corpus luteum of pregnancy, continues to produce progesterone during early gestation.
This maintains endometrial support while placental steroidogenic capacity develops.
As pregnancy progresses, the placenta becomes capable of producing sufficient progesterone to assume the major role previously performed by the corpus luteum.
This shift is commonly referred to as the luteal-placental transition.
The placenta becomes a major source of progesterone during pregnancy. Placental trophoblast cells use maternal cholesterol as an important substrate for steroid synthesis.
Progesterone produced by the placenta enters both maternal and fetal circulations and supports the hormonal environment of pregnancy.
Progesterone has multiple roles during pregnancy. It supports the decidualized endometrium, contributes to uterine quiescence, participates in immunological regulation at the maternal-fetal interface, and supports mammary gland development.
Its actions are integrated with those of estrogens, hCG, human placental lactogen, prolactin, and numerous local mediators.
The decidua is the specialized endometrium of pregnancy. Progesterone is essential for maintaining its differentiated state and supporting the maternal environment surrounding the implanted conceptus.
Progesterone contributes to regulation of cellular and molecular processes at the maternal-fetal interface. These mechanisms help create an environment compatible with continued pregnancy.
Pregnancy maintenance, however, depends on a complex network of endocrine, immune, vascular, and placental factors rather than progesterone alone.
Parturition requires a transition from uterine quiescence to coordinated myometrial contractility. In humans, this transition involves changes in progesterone signaling rather than simply a dramatic fall in circulating progesterone before labor.
Alterations in progesterone receptor function, estrogenic signaling, prostaglandins, oxytocin responsiveness, and inflammatory pathways contribute to the onset of labor.
The term functional progesterone withdrawal describes reduced progesterone-mediated restraint of uterine activation despite continued relatively high circulating progesterone concentrations near term.
Changes in receptor isoforms and downstream signaling are among the mechanisms involved.
Progesterone exerts many of its actions through progesterone receptors (PRs), members of the nuclear receptor superfamily.
Important classical receptor isoforms include PR-A and PR-B.
PR-A and PR-B arise from the same gene but differ in their structure and transcriptional activity.
The relative expression and activity of these receptor isoforms can influence tissue-specific responses to progesterone.
Progesterone diffuses across the plasma membrane and binds intracellular progesterone receptors. Ligand binding alters receptor conformation and allows regulation of gene transcription.
The resulting changes in gene expression contribute to the relatively sustained actions of progesterone in target tissues.
Activated progesterone receptors interact with regulatory DNA sequences and transcriptional cofactors to modify expression of progesterone-responsive genes.
The genes affected differ among the uterus, breast, brain, and other target tissues.
Progesterone can also produce relatively rapid cellular effects through mechanisms that do not depend exclusively on classical nuclear transcription.
Membrane-associated progesterone signaling contributes to the diversity of progesterone responses in different tissues.
Estrogen increases progesterone receptor expression in several reproductive tissues. Consequently, estrogen exposure during the follicular phase helps prepare tissues to respond to progesterone after ovulation.
This is an important example of hormonal interaction within reproductive physiology.
Estrogen and progesterone frequently produce sequential and complementary effects. Estrogen promotes proliferation, while progesterone often promotes differentiation of estrogen-primed reproductive tissues.
The endometrium provides the clearest example of this relationship.
| Stage | Dominant Hormonal Influence | Endometrial Response |
|---|---|---|
| Menstrual phase | Withdrawal of ovarian steroids | Shedding of functional layer |
| Proliferative phase | Estrogen | Regrowth and proliferation |
| Secretory phase | Progesterone after estrogen priming | Secretory differentiation and preparation for implantation |
Because progesterone is hydrophobic, most circulating progesterone is associated with plasma proteins.
It binds principally to albumin and also to corticosteroid-binding globulin, while a relatively small fraction circulates unbound.
Progesterone is extensively metabolized, particularly in the liver. Its metabolites undergo additional modification and conjugation before elimination.
One important metabolite is pregnanediol, which can be excreted in conjugated form in urine.
Progesterone has a thermogenic effect. Following ovulation, the progesterone-dominant luteal phase is associated with a small increase in basal body temperature.
This physiological change has historically been used as an indirect indicator that ovulation has occurred.
Basal body temperature typically increases after ovulation and remains relatively elevated during the luteal phase. If pregnancy does not occur, it generally falls as the corpus luteum regresses and progesterone declines.
Temperature patterns are indirect and can be influenced by many nonreproductive factors.
Progesterone can stimulate respiratory drive. Increased progesterone during pregnancy contributes to changes in maternal ventilation.
This illustrates the systemic actions of progesterone beyond the reproductive organs.
Progesterone and its metabolites can influence neural function. Progesterone receptors are expressed within the brain, and some progesterone metabolites interact with neurotransmitter systems.
These actions contribute to the broader neuroendocrine effects of reproductive steroid hormones.
Allopregnanolone is a neuroactive metabolite of progesterone that can modulate GABAA receptor activity.
It illustrates how metabolism of a steroid hormone can generate biologically active compounds with actions distinct from those mediated by classical nuclear progesterone receptors.
Progesterone is also present in males, although circulating concentrations are generally lower than luteal-phase concentrations in females.
It serves as an intermediate in steroidogenesis and can exert biological effects through progesterone receptors in multiple tissues.
Within the adrenal cortex, progesterone-related intermediates participate in pathways leading to glucocorticoids, mineralocorticoids, and adrenal androgens.
The specific steroid products generated depend on the enzyme complement of each adrenal cortical zone.
Within the ovary, progesterone participates both as a secreted hormone and as a steroidogenic intermediate. The dominant steroid products change according to follicular stage, cell type, gonadotropin stimulation, and enzyme expression.
During the luteal phase, the corpus luteum produces both progesterone and inhibin A. These hormones contribute through different mechanisms to suppression of pituitary gonadotropin secretion.
Progesterone contributes broader hypothalamic-pituitary negative feedback, while inhibin A is particularly important for selective suppression of FSH.
Inadequate progesterone exposure can impair normal secretory transformation of the endometrium and may occur when ovulation or corpus luteum function is disrupted.
Interpretation of progesterone status requires consideration of menstrual timing, ovulatory status, pregnancy status, and the clinical context.
In an anovulatory cycle, a normal postovulatory corpus luteum does not form. Consequently, the characteristic luteal rise in progesterone is absent.
The endometrium may therefore remain under predominantly estrogenic influence rather than undergoing normal progesterone-dependent secretory differentiation.
When endometrial estrogenic stimulation occurs without adequate opposing progesterone, prolonged proliferative signaling can result.
This concept is important for understanding the relationship between chronic anovulation and abnormal endometrial proliferation.
Serum progesterone measurement can provide information about luteal activity when interpreted in relation to the timing of the ovarian cycle.
Because progesterone secretion can fluctuate substantially, a single measurement has limitations and must be interpreted in its clinical context.
A rise in progesterone after the expected time of ovulation provides biochemical evidence of luteal activity and is commonly used as an indirect indicator that ovulation has occurred.
The interpretation depends on appropriate timing because progesterone is normally low during the follicular phase.
During early pregnancy, progesterone production by the corpus luteum is maintained by hCG. Progesterone supports the decidualized endometrium during the period before placental steroidogenesis becomes sufficient.
The relationship among hCG, the corpus luteum, progesterone, and the endometrium is therefore fundamental to early pregnancy endocrinology.
| Feature | Progesterone | Estrogen |
|---|---|---|
| Hormone class | Steroid | Steroid |
| Major cyclic source | Corpus luteum | Developing ovarian follicle |
| Dominant cycle phase | Luteal phase | Follicular phase |
| Major endometrial action | Secretory differentiation | Proliferation |
| Cervical mucus | Generally thicker after ovulation | Thin and more permeable near ovulation |
| Breast effect | Promotes lobuloalveolar development | Promotes ductal development |
| Feedback | Predominantly negative feedback | Negative feedback and preovulatory positive feedback |
| Feature | Progesterone | Inhibin |
|---|---|---|
| Hormone type | Steroid | Glycoprotein |
| Important luteal source | Corpus luteum | Corpus luteum, particularly inhibin A |
| Major feedback action | Hypothalamic-pituitary negative feedback | Selective suppression of FSH |
| Major peripheral role | Endometrial differentiation and pregnancy support | Primarily reproductive endocrine regulation |
| Event | Progesterone Relationship |
|---|---|
| Follicular development | Progesterone remains relatively low |
| LH surge | Initiates luteinization leading to increased progesterone production |
| Ovulation | Followed by formation of progesterone-producing corpus luteum |
| Secretory phase | Driven largely by progesterone acting on estrogen-primed endometrium |
| No pregnancy | Corpus luteum regresses and progesterone falls |
| Menstruation | Triggered in part by withdrawal of progesterone and estrogen |
| Pregnancy | Progesterone production is maintained, initially through corpus luteum rescue by hCG |
| Stage | Major Progesterone Source or Function |
|---|---|
| Immediately after ovulation | Corpus luteum prepares endometrium for implantation |
| Early pregnancy | hCG maintains corpus luteum progesterone production |
| Developing pregnancy | Placental progesterone production increases |
| Established pregnancy | Placenta is the major progesterone source |
| Throughout pregnancy | Supports decidua and contributes to uterine quiescence and mammary development |
| Feature | Key Point |
|---|---|
| Hormone type | Steroid hormone |
| Precursor | Cholesterol |
| Major cyclic source | Corpus luteum |
| Major pregnancy source | Placenta after early luteal support |
| Dominant ovarian-cycle phase | Luteal phase |
| Major uterine target | Endometrium and myometrium |
| Endometrial effect | Secretory differentiation and decidual support |
| Major receptors | PR-A and PR-B |
| Feedback | Predominantly negative within the HPG axis |
| Pregnancy role | Supports the endometrium and contributes to uterine quiescence |
| Breast effect | Promotes lobuloalveolar development |
| Temperature effect | Raises basal body temperature after ovulation |
Progesterone provides the major endocrine link between ovulation and preparation of the uterus for pregnancy. The LH surge transforms the ruptured ovarian follicle into the corpus luteum, changing the ovary from a predominantly estrogen-producing follicular organ into a progesterone-dominant luteal endocrine organ.
The endometrium demonstrates the importance of sequential ovarian hormone action. Estrogen first stimulates proliferation during the follicular phase. Progesterone then acts on the estrogen-primed endometrium after ovulation, converting proliferative glands and stroma into a differentiated secretory tissue capable of supporting implantation. If pregnancy does not occur, regression of the corpus luteum removes progesterone support and contributes to menstruation.
If pregnancy occurs, trophoblastic hCG prevents the normal early regression of the corpus luteum. Continued luteal progesterone secretion maintains the endometrium until placental steroidogenesis becomes sufficiently established. The placenta then assumes the major role in progesterone production, supporting the decidua and contributing to a relatively quiescent uterus throughout gestation.
Progesterone also illustrates the integration of reproductive anatomy with endocrine feedback. Its production depends on structural transformation of the ovarian follicle, while its actions extend to the uterus, cervix, uterine tubes, breast, hypothalamus, pituitary, brain, and other tissues. Progesterone receptors allow these tissues to translate the circulating hormonal signal into tissue-specific responses.
Through these coordinated actions, progesterone regulates the transition from ovulation to the luteal phase, prepares the reproductive tract for implantation, supports early and established pregnancy, contributes to mammary differentiation, and helps control the cyclic activity of the hypothalamic-pituitary-ovarian axis.